Nitric oxide for the prevention and treatment of viral, bacterial, protozoal and fungal infections
Open Access
- 5 July 2021
- journal article
- Published by F1000 Research Ltd in F1000Research
- Vol. 10, 536
- https://doi.org/10.12688/f1000research.51270.1
Abstract
Although the antimicrobial potential of nitric oxide (NO) is widely published, it is little used clinically. NO is a key signalling molecule modulating vascular, neuronal, inflammatory and immune responses. Endogenous antimicrobial activity is largely mediated by high local NO concentrations produced by cellular inducible nitric oxide synthase, and by derivative reactive nitrogen oxide species including peroxynitrite and S-nitrosothiols. NO may be taken as dietary substrate (inorganic nitrate, L-arginine), and therapeutically as gaseous NO, and transdermal, sublingual, oral, intranasal and intravenous nitrite or nitrate. Numerous preclinical studies have demonstrated that NO has generic static and cidal activities against viruses (including β-coronaviruses such as SARS-CoV-2), bacteria, protozoa and fungi/yeasts in vitro. Therapeutic effects have been seen in animal models in vivo, and phase II trials have demonstrated that NO donors can reduce microbial infection. Nevertheless, excess NO, as occurs in septic shock, is associated with increased morbidity and mortality. In view of the dose-dependent positive and negative effects of NO, safety and efficacy trials of NO and its donors are needed for assessing their role in the prevention and treatment of infections. Trials should test dietary inorganic nitrate for pre- or post-exposure prophylaxis and gaseous NO or oral, topical or intravenous nitrite and nitrate for treatment of mild-to-severe infections, including due to SARS-CoV-2 (COVID-19). This review summarises the evidence base from in vitro, in vivo and early phase clinical studies of NO activity in viral, bacterial, protozoal and fungal infections.Keywords
Funding Information
- No funding
This publication has 99 references indexed in Scilit:
- Examination of bacterial resistance to exogenous nitric oxideNitric Oxide, 2012
- Acute effect of a high nitrate diet on brain perfusion in older adultsNitric Oxide, 2011
- Nitric oxide is elicited and inhibits viral replication in pigs infected with porcine respiratory coronavirus but not porcine reproductive and respiratory syndrome virusVeterinary Immunology and Immunopathology, 2010
- What is the real physiological NO concentration in vivo?Nitric Oxide, 2009
- Nitric oxide inhibits the replication cycle of porcine parvovirus in vitroArchiv für die gesamte Virusforschung, 2009
- Nitric oxide and peroxynitrite have different antiviral effects against hantavirus replication and free mature virionsEuropean Journal of Immunology, 2006
- Iloprost: an adjunctive approach to chronic viral hepatitis treatmentMedical Hypotheses, 2005
- Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesisMutation research. Reviews in mutation research, 1994
- Interleukin‐4 and interleukin‐10 inhibit nitric oxide‐dependent macrophage killing of Candida albicansEuropean Journal of Immunology, 1993
- The role of nitric oxide and cGMP in platelet adhesion to vascular endotheliumBiochemical and Biophysical Research Communications, 1987